Cardiol Therapeutics Announces Phase II ARCHER Trial Presented at the World Congress on Acute Heart Failure 2024 Geography
Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results Life Science Investing
Annexon Reports First Quarter 2024 Financial Results and Key Anticipated Milestones Life Science Investing
MiNK Therapeutics Announces $5.8 Million Private Placement and Appointment of Board Observer Life Science Investing
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2024 Financial Results Life Science Investing
Praxis Precision Medicines to Report First Quarter 2024 Financial Results on Monday, May 13, 2024 Life Science Investing
ARS Pharmaceuticals Highlights neffy Regulatory Progress and Reports First Quarter 2024 Financial Results Life Science Investing
